Spyre Therapeutics
SYRE
#5838
Rank
A$1.27 B
Marketcap
$21.15
Share price
-8.58%
Change (1 day)
-60.61%
Change (1 year)

Earnings for Spyre Therapeutics (SYRE)

Earnings in 2024 (TTM): -A$0.32 Billion

According to Spyre Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spyre Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.35 Billion62.23%
2023 -A$0.22 Billion51.64%
2022 -A$0.15 Billion29.14%
2021 -A$0.11 Billion-19.43%
2020 -A$0.14 Billion1.43%
2019 -A$0.14 Billion76.7%
2018 -A$75.2 Million64.27%
2017 -A$45.78 Million26.34%
2016 -A$36.24 Million93.6%
2015 -A$18.72 Million27.08%
2014 -A$14.73 Million